Literature DB >> 19539269

Catechol-O-methyltransferase valine(158)methionine polymorphism modulates brain networks underlying working memory across adulthood.

Fabio Sambataro1, Jeff D Reed, Vishnu P Murty, Saumitra Das, Hao Yang Tan, Joseph H Callicott, Daniel R Weinberger, Venkata S Mattay.   

Abstract

BACKGROUND: Cognitive abilities decline with age with large individual variability. Genetic variations have been suggested to be an important source for some of this heterogeneity. Among these variations, those related to the dopaminergic system, particularly the valine(158)methionine polymorphism in catechol-O-methyltransferase (COMTval(158)met), have been implicated in modulating age-related changes in executive function.
METHODS: We studied 75 subjects (age 21-90 years) using functional neuroimaging while they performed a low-level working memory (WM) task to explore the effects of aging, of the COMTval(158)met polymorphism, and their interactions on the physiological patterns of interconnected cortical activity engaged by WM.
RESULTS: Our results show that val homozygotes and older subjects showed increased activity in dorsolateral prefrontal cortex (DLPFC) and decreased activity in ventrolateral prefrontal cortex (VLPFC) relative to met homozygotes and younger subjects, respectively. Interestingly, there were also independent effects of the COMTval(158)met polymorphism and age on the strength of connectivity between brain regions within the left prefrontal-parietal network; val homozygotes and older subjects showed greater connectivity between the DLPFC and other brain regions within the network and met homozygotes showed greater connectivity between the VLPFC and other brain regions within the network. Furthermore, the greater functional connectivity strength of DLPFC in val homozygotes relative to met homozygotes was much more pronounced in older adults
CONCLUSIONS: Our findings suggest that the COMTval(158)met polymorphism modulates both the activity and functional connectivity of brain regions within WM networks and most importantly that this effect is exaggerated with increasing age, contributing to the variability in age-related decline in executive cognition.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19539269      PMCID: PMC3085346          DOI: 10.1016/j.biopsych.2009.04.014

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  52 in total

1.  Modulation of oscillatory neuronal synchronization by selective visual attention.

Authors:  P Fries; J H Reynolds; A E Rorie; R Desimone
Journal:  Science       Date:  2001-02-23       Impact factor: 47.728

2.  Dopamine transporters decrease with age.

Authors:  N D Volkow; Y S Ding; J S Fowler; G J Wang; J Logan; S J Gatley; R Hitzemann; G Smith; S D Fields; R Gur
Journal:  J Nucl Med       Date:  1996-04       Impact factor: 10.057

3.  Independent component model of the default-mode brain function: Assessing the impact of active thinking.

Authors:  Fabrizio Esposito; Alessandro Bertolino; Tommaso Scarabino; Valeria Latorre; Giuseppe Blasi; Teresa Popolizio; Gioacchino Tedeschi; Sossio Cirillo; Rainer Goebel; Francesco Di Salle
Journal:  Brain Res Bull       Date:  2006-07-21       Impact factor: 4.077

4.  Analysis of fMRI data by blind separation into independent spatial components.

Authors:  M J McKeown; S Makeig; G G Brown; T P Jung; S S Kindermann; A J Bell; T J Sejnowski
Journal:  Hum Brain Mapp       Date:  1998       Impact factor: 5.038

5.  Cocaine administration decreases functional connectivity in human primary visual and motor cortex as detected by functional MRI.

Authors:  S J Li; B Biswal; Z Li; R Risinger; C Rainey; J K Cho; B J Salmeron; E A Stein
Journal:  Magn Reson Med       Date:  2000-01       Impact factor: 4.668

6.  Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine.

Authors:  Venkata S Mattay; Terry E Goldberg; Francesco Fera; Ahmad R Hariri; Alessandro Tessitore; Michael F Egan; Bhaskar Kolachana; Joseph H Callicott; Daniel R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

7.  Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex.

Authors:  E M Tunbridge; D M Bannerman; T Sharp; P J Harrison
Journal:  J Neurosci       Date:  2004-06-09       Impact factor: 6.167

Review 8.  Computational models of schizophrenia and dopamine modulation in the prefrontal cortex.

Authors:  Edmund T Rolls; Marco Loh; Gustavo Deco; Georg Winterer
Journal:  Nat Rev Neurosci       Date:  2008-09       Impact factor: 34.870

9.  Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice.

Authors:  Francesco Papaleo; Jacqueline N Crawley; Jian Song; Barbara K Lipska; Jim Pickel; Daniel R Weinberger; Jingshan Chen
Journal:  J Neurosci       Date:  2008-08-27       Impact factor: 6.167

10.  The functional COMT polymorphism, Val 158 Met, is associated with logical memory and the personality trait intellect/imagination in a cohort of healthy 79 year olds.

Authors:  Sarah E Harris; Alan F Wright; Caroline Hayward; John M Starr; Lawrence J Whalley; Ian J Deary
Journal:  Neurosci Lett       Date:  2005-09-02       Impact factor: 3.046

View more
  27 in total

Review 1.  The cognitive neuroscience of ageing.

Authors:  Cheryl Grady
Journal:  Nat Rev Neurosci       Date:  2012-06-20       Impact factor: 34.870

2.  Dopamine-dependent cognitive processes after menopause: the relationship between COMT genotype, estradiol, and working memory.

Authors:  Julie A Dumas; Jenna A Makarewicz; Janice Bunn; Joshua Nickerson; Elizabeth McGee
Journal:  Neurobiol Aging       Date:  2018-08-16       Impact factor: 4.673

Review 3.  Genetics and functional imaging: effects of APOE, BDNF, COMT, and KIBRA in aging.

Authors:  Goran Papenberg; Alireza Salami; Jonas Persson; Ulman Lindenberger; Lars Bäckman
Journal:  Neuropsychol Rev       Date:  2015-02-10       Impact factor: 7.444

4.  Genetic markers of dopaminergic transmission predict performance for older males but not females.

Authors:  Kathleen E Hupfeld; David E Vaillancourt; Rachael D Seidler
Journal:  Neurobiol Aging       Date:  2018-02-10       Impact factor: 4.673

5.  Altered cerebral response during cognitive control: a potential indicator of genetic liability for schizophrenia.

Authors:  Fabio Sambataro; Venkata S Mattay; Kristina Thurin; Martin Safrin; Roberta Rasetti; Giuseppe Blasi; Joseph H Callicott; Daniel R Weinberger
Journal:  Neuropsychopharmacology       Date:  2012-12-05       Impact factor: 7.853

6.  The effects of the COMT Val108/158Met polymorphism on BOLD activation during working memory, planning, and response inhibition: a role for the posterior cingulate cortex?

Authors:  Paul R A Stokes; Rebecca A Rhodes; Paul M Grasby; Mitul A Mehta
Journal:  Neuropsychopharmacology       Date:  2010-12-08       Impact factor: 7.853

7.  COMT genotype and cognitive function: an 8-year longitudinal study in white and black elders.

Authors:  A J Fiocco; K Lindquist; R Ferrell; R Li; E M Simonsick; M Nalls; T B Harris; K Yaffe
Journal:  Neurology       Date:  2010-04-20       Impact factor: 9.910

8.  Normal aging modulates prefrontoparietal networks underlying multiple memory processes.

Authors:  Fabio Sambataro; Martin Safrin; Herve S Lemaitre; Sonya U Steele; Saumitra B Das; Joseph H Callicott; Daniel R Weinberger; Venkata S Mattay
Journal:  Eur J Neurosci       Date:  2012-08-21       Impact factor: 3.386

9.  Cortical development and glutamatergic dysregulation in schizophrenia.

Authors:  Akira Sawa
Journal:  Biol Psychiatry       Date:  2009-09-15       Impact factor: 13.382

10.  The catechol-o-methyltransferase Val158 Met polymorphism modulates organization of regional cerebral blood flow response to working memory in adults.

Authors:  Alicia F Heim; Melissa J Coyne; M Ilyas Kamboh; Christopher Ryan; J Richard Jennings
Journal:  Int J Psychophysiol       Date:  2013-06-26       Impact factor: 2.997

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.